Live event: Thursday 19 October 2017 at 07:00 [PDT] 10:00 [EDT] 15:00 [BST]
We want to assess and mitigate risk from pre-existing antibodies early within clinical development. Will pre-existing antibodies impact our clinical trial?
Live event: Thursday 12 October 2017 at 07:00 [PDT] 10:00 [EDT] 15:00 [BST]
Gain first-hand experience from a CRO on their transition from small molecule bioanalysis to biologics.
Available to view on demand: In this webinar, Glenn Petrie discusses best practice in optimizing the Chemistry, Manufacturing and Control (CMC) process.
Live event: Tuesday 3 October 2017 at 07:00 [PDT] 10:00 [EDT] 15:00 [BST]
This webinar will explore this continuum of fit-for-purpose validation, from the validation of early exploratory biomarker analysis, to the amalgamation of FDA GLP and CLIA GLP biomarker validation guidelines in the bioanalytical lab.
Available to view on demand: In this webinar, Kenneth Brouwer outlines the initiating events and the hepatocyte’s response in the regulation of bile acids.
In this webinar Kyunghee Yang and Kenneth Brouwer outline the species differences in the hepatobiliary disposition and regulation of bile acids.
Live event: Thursday, Oct 5, 2017 5:00 PM – 6:00 [BST].
In this webinar, James Schmidt discusses stereo-selectivity in drug metabolism.
Live event: Thursday 5 October 2017 at 08:00 [PDT] 11:00 [EDT] 16:00 [BST]
Experts in microsampling share their knowledge and experience of what is required to complete a successful implementation, with insights for anyone struggling with a new and disruptive technology.
Available on demand
Altasciences’ experts share their most recent experience using Volumetric Absorptive Microsampling Mitra™ technology from product characterization to application development, highlighted with specific case studies.
Live event: Tuesday 31 October 2017 at 07:00 [PDT] 10:00 [EDT] 14:00 [BST]
In this presentation, the results of an exploration of HRMS for the quantitative determination of biopharmaceutical proteins and a comparison to nominal mass LC-MS/MS will be provided, including validation results and application to preclinical trials.
Available to view on demand.
Introduction of the Axolabs PNA-HPLC Assay for selective and sensitive bioanalysis of all kinds therapeutically relevant oligonucleotide entities up to 100nt in length.
Available to view on demand
During this panel discussion, our experts will analyze key results from our survey on oligonucleotides, giving a comprehensive overview on the current applications and the future trends of oligonucleotide analysis.
A recent metabolomics study has identified biomarkers from particular foods, which could help in establishing the connection between diet and Type 2 Diabetes, quantitatively.
Researchers have designed a camera capable of diagnostic optical spectroscopy, incorporated into the body of a smartphone.
Invicro, an imaging services company, announced the acquisition of Imanova, a UK-based imaging and translational research company.
In this review article the authors summarize the current development of functional oligonucleotides, called aptamers, focusing on the diagnostic and therapeutic applications.
Weiping Shao discusses biomarkers, immunogenicity and the work he contributes to at Regeneron Pharmaceuticals (NY,USA).
Bioanalysis Zone and Bioanalysis attended the 11th WRIB meeting in Los Angeles (CA, USA) and had the opportunity to host a panel discussion with experts from leading pharmaceutical companies and CROs to discuss several contemporary topics including: emerging technologies; recurring and talent development; and mergers and acquisitions.